Theravance Says FDA Delays New Vitabiv Decision
Theravance says FDA wants more data before ruling on Vitabix for hospital-acquired pneumonia
02:45PM 11/27/09
Takeout Rumors Lift Dendreon, Bio Stocks: BioBuzz
On a strong day for the sector, the buyout rumors are buzzing
03:18PM 09/14/09
Auxilium Shares Higher On FDA Drug Review: BioBuzz
FDA doesn't raise new safety issues for Auxilium's hand treatment
11:01AM 09/14/09
XOMA to Repay Goldman Loan: BioBuzz
Drug company removes overhang on balance sheet
08:55AM 09/14/09
Cell Therapeutics CEO Sells Stock: BioBuzz
Jim Bianco unloads 30% of holdings days after investor meeting
06:40AM 09/14/09
Biotech Calendar: Key Dates and Events
A quick and dirty guide to important biotech events for the busy month of September.
09:00AM 08/18/09
Biotech Calendar: Key FDA Action Dates
A quick and dirty guide to upcoming FDA approval dates for biotech drugs.
11:57AM 08/05/09
When Seth Klarman Speaks, You'd Better Listen (RealMoney.com $)
His Baupost fund's latest 13-F filing suggests some investment themes.
02:30PM 05/19/09
Theravance 1Q Loss Narrows On Cuts, Revenue Boost
Theravance's 1st-quarter loss narrows on cost cuts, higher revenue from partnerships
05:18PM 04/22/09
Medicines Co. to Acquire Targanta
The minimum price tag of the deal is $42 million.
12:47PM 01/13/09
FDA Declines to Approve Targanta Antibiotic
The FDA has deemed two trials for oritavancin insufficient for approval.
01:07PM 12/09/08
Biotech Stocks Burn Higher on M&A Fire
The sector is trading higher on today's buyout bid. One analyst offers a list of who else could tie the knot in the drug and biotech space.
12:44PM 07/31/08
Tuesday's Winners & Losers: Theravance
Shares dive 28% on signs of further regulatory delays for its drug telavancin.
04:37PM 03/04/08



Connect with TheStreet